Misfolded Proteins May Explain a Hidden Share of Inherited Deafness

Hearing loss is the most common sensory deficit in humans, affecting roughly five percent of the world’s population, and a substantial fraction of that burden is inherited. Yet for many families who carry a genetic diagnosis of deafness, the exact molecular culprit remains frustratingly out of reach. A new study published in PLOS Genetics tackles this diagnostic gap at scale, and its central finding is striking: a large proportion of the thousands of unclassified DNA variants linked to hereditary hearing loss may act through a single, physically coherent mechanism—protein misfolding. By combining population genetics data with biophysical calculations of protein stability, the research team, led by Rose A. Gogal and Michael J. Schnieders at the University of Iowa, has reclassified tens of thousands of previously ambiguous variants and, in doing so, upgraded real clinical diagnoses for affected patients.

The scale of the problem the researchers confronted is enormous. The Deafness Variation Database, or DVD, a public resource that catalogs genetic variants associated with hearing loss, contains 381,924 missense variants spread across 224 genes. Missense variants are single-letter changes in DNA that swap one amino acid for another in the resulting protein, and they are notoriously difficult to interpret. Of those 381,924 variants, 303,577—nearly four out of five—are classified as variants of uncertain significance, or VUS. A VUS is essentially a genetic placeholder: laboratory testing has detected a change, but no one can say with confidence whether it disrupts hearing or is harmless. For families, that uncertainty translates into unresolved diagnoses, ambiguous reproductive counseling, and the psychological weight of an answer that is not really an answer.

Professional guidelines from the American College of Medical Genetics and Genomics, known as ACMG/AMP, allow computational evidence to contribute to variant classification, but they leave open exactly how different lines of computational evidence should be weighed and combined. The Iowa team approached this as a formal statistical problem. They built a family of Bayesian models—probabilistic frameworks that start with a prior belief about how likely a variant is to be pathogenic and then update that belief as evidence accumulates. Each type of computational evidence, from an algorithm score to a gene-level property, contributes a quantified strength of evidence expressed in the likelihood ratios that ACMG/AMP recommendations envision. The advantage of this approach is transparency: rather than a black-box verdict, every classification can be traced to explicit, auditable numerical inputs.

The first question the researchers addressed was which of the existing variant-scoring tools deserves the most weight. They compared two widely used predictors, CADD and REVEL, using Bayesian models trained on two different reference datasets: a 2019 snapshot of ClinVar, a public archive of variant interpretations, and a set of variants already labeled within the Deafness Variation Database itself. When accuracy, sensitivity, and specificity were measured head to head, the REVEL model built on the DVD-labeled variants came out on top. That result carries a practical lesson for the field: predictors calibrated on disease-specific, curated data can outperform general-purpose scores, and evidence frameworks for hearing loss should draw on resources tailored to the genes and phenotypes actually at stake.

The team then added a second layer of evidence drawn from evolutionary biology. Genes differ in how tolerant they are to missense change: some proteins can absorb many amino-acid substitutions without losing function, while others are so finely tuned that almost any change is deleterious. Sorting the 224 deafness genes into three bins—tolerant, average, and intolerant—revealed a clear gradient in baseline risk. Variants in intolerant genes carried a prior probability of pathogenicity of 25.7 percent, more than double the 10.7 percent seen in average genes and nearly triple the 8.7 percent in tolerant genes. In other words, the same DNA letter change means something quite different depending on the evolutionary constraint of the gene it lands in, and the Bayesian framework now accounts for that context explicitly.

The most consequential innovation, however, was biophysical. Many missense variants do their damage not by sabotaging a protein’s active site directly but by destabilizing the protein’s three-dimensional fold. A protein that cannot hold its shape is typically degraded by cellular quality-control machinery or accumulates in misfolded, dysfunctional forms, and either outcome can starve the delicate hair cells of the inner ear of the proteins they need to survive and transmit sound. The researchers incorporated predicted changes in folding stability into their Bayesian model, estimating how many kilocalories per mole of destabilization each variant would impose. This protein-folding-informed model outperformed the simpler versions, and crucially it did something the score-based models cannot: it supplied a mechanistic rationale, explaining not just that a variant is likely harmful but how it would break the protein.

The numbers that emerged from this analysis are remarkable. Of the 381,924 missense variants in the database, 54,752—14.3 percent of the total—are predicted to cause modest destabilization of more than 1.0 kilocalorie per mole. A stricter threshold of at least 2.0 kilocalories per mole, indicating more severe structural disruption, captures 22,237 variants, or 6.2 percent of the database. When the analysis is restricted to the prioritized variants of uncertain significance, the fractions climb steeply: 34 percent of prioritized VUSs fall into the modest-destabilization category, and 55.8 percent fall into the severe category. Taken together, the findings suggest that protein misfolding is not an occasional curiosity among deafness variants but a prevalent mechanism, plausibly underlying a large share of hereditary hearing loss that has resisted explanation.

The framework’s power is not merely statistical. Using the protein-folding-informed model, 28,866 variants of uncertain significance reached a posterior probability of pathogenicity above 98 percent and were prioritized as likely pathogenic. From that prioritized set, the team identified twelve probands—individual patients in the database whose genetic diagnoses could be upgraded from uncertain to likely pathogenic or pathogenic. For those twelve families, computational biophysics converted an ambiguous test result into an actionable diagnosis, with implications for prognosis, surveillance, and reproductive counseling. The study also highlights two specific variants that cause clear structural disruption of their proteins, illustrating concretely how biophysical characterization can settle cases that sequence data alone leave open.

Why does the inner ear appear so vulnerable to this particular failure mode? The sensory hair cells that convert mechanical vibration into neural signals are packed with precisely assembled protein complexes, from ion channels to the tip-link proteins of the hair bundle, and many of them are long-lived and rarely replaced. A modest thermodynamic nudge toward unfolding, tolerable in a rapidly turning-over tissue, can be catastrophic in a cell that must last a lifetime. The new findings give that intuition quantitative teeth, showing that destabilization thresholds of one to two kilocalories per mole—small on the scale of protein energetics—correspond to a meaningful probability of disease.

The broader implications reach beyond deafness. Variant interpretation is the bottleneck of modern genomic medicine, and the Iowa study demonstrates a template for breaking it: combine disease-specific curated databases, gene-level evolutionary constraint, and protein-folding physics inside a transparent Bayesian framework aligned with professional guidelines. The same architecture could, in principle, be adapted to cardiomyopathies, epileptic encephalopathies, or any inherited disorder dominated by missense variation. For the hundreds of thousands of families still holding variants of uncertain significance in deafness genes, the message is one of cautious optimism: a large fraction of those ambiguities may now be resolvable, not by waiting for more families to be reported, but by calculating what the variant does to the protein it touches. Twelve diagnoses have already been changed; the framework suggests many more are waiting.

Subject of Research: Computational assessment of protein misfolding as a mechanism of hereditary deafness

Article Title: The prevalence of protein misfolding as a mechanism for hereditary deafness

Article References: Gogal, R. A., Cox, G. M., Kolbe, D. L., Odell, A. M., Ovel, C. E., McCormick, K. I., Hong, B., Azaiez, H., Casavant, T. L., Smith, R. J. H., Braun, T. A., & Schnieders, M. J. (2026). The prevalence of protein misfolding as a mechanism for hereditary deafness. PLOS Genetics, 22(9), e1012085. https://doi.org/10.1371/journal.pgen.1012085

Image Credits: AI Generated

DOI: 10.1371/journal.pgen.1012085

Keywords: hereditary deafness, protein misfolding, variant of uncertain significance, Deafness Variation Database, Bayesian model, missense variants, protein stability, ACMG/AMP guidelines, genetic diagnosis, PLOS Genetics, hair cells, variant interpretation